Synthesis and biological evaluation of polyhydroxy benzophenone as mushroom tyrosinase inhibitors

References

• Song K. K., Huang H., Han P., Zhang C. L., Shi Y., Chen Q. X., Inhibitory effects of cis- and trans-isomers of 3,5-dihydroxystilbene on the activity of mushroom tyrosinase. Biochem. Biophys. Res. Commun. 2006, 342, 1147–1151.
   PubMed Web of Science ®Google Scholar
• Yokochi N., Morita T., Yagi T., Inhibition of diphenolase activity of tyrosinase by vitamin B6 compounds. J. Agric. Food Chem. 2003, 51, 2733–2736.
   Google Scholar
• Hearing V. J., Tsukamoto K. Enzymic control of pigmentation in mammals. FASEB J. 1991, 5, 2902–2909.
   PubMed Web of Science ®Google Scholar
• Nerya O., Musa R., Khatib S., Tamir S., Vaya J., Chalcones as potent tyrosinase inhibitors: the effect of hydroxyl positions and numbers. Phytochemistry 2004, 65, 1389–1395.
   PubMed Web of Science ®Google Scholar
• Maeda K., Fukuda M., In vitro effectiveness of several whitening cosmetic components in human melanocytes. J. Soc. Cosmet. Chem. 1991, 42, 361–363.
   Web of Science ®Google Scholar
• Maeda K., Fukuda M., Arbutin: mechanism of its depigmenting action in human melanocyte culture. J. Pharm. Exp. Ther. 1996, 276, 765–769.
   PubMed Web of Science ®Google Scholar
• Chen Q. X., Kubo I., Kinetics of mushroom tyrosinase inhibition by quercetin. J. Agric. Food Chem. 2002, 50, 4108–4112.
   PubMed Web of Science ®Google Scholar
• ShiinoM., Watanabe Y., Umezawa K., Synthesis of N-substituted N-nitrosohydroxylamines as inhibitors of mushroom tyrosinase. Bioorg. Med. Chem. 2001, 9, 1233–1240.
   PubMed Web of Science ®Google Scholar
• Seo S. Y., Sharma V. K., Sharma N., Mushroom tyrosinase: recent prospects. J. Agric. Food Chem. 2003, 51, 2837–2853.
   PubMed Web of Science ®Google Scholar
• Kubo I., Kinst-Hori I., 2-Hydroxy-4-methoxybenzaldehyde. A potent tyrosinase inhibitor from African medicinal plants. Planta Med. 1999, 65, 19–22.
   PubMed Web of Science ®Google Scholar
• Okombi S., Rival D., Bonnet S., Mariotte A. M., Perrier E., Boumendjel A., Discovery of benzylidenebenzofuran-3(2H)-one (aurones) as inhibitors of tyrosinase derived from human melanocytes. J. Med. Chem. 2006, 49, 329–333.
   PubMed Web of Science ®Google Scholar
• Khatib S., Nerya O., Musa R., Tamir S., Pete T., Vaya J., Enhanced substituted resorcinol hydrophobicity augments tyrosinase inhibition potency. J. Med. Chem. 2007, 50, 2676–2681.
   PubMed Web of Science ®Google Scholar
• Arandt K. A., Fitzpatrick T. B., Topical use of hydroquinine as a depigmenting agent. J. Am. Med. Assoc. 1965, 194, 117–119.
   Web of Science ®Google Scholar
• Fitztrick T. B., Arandt K. A., El-Mofty A. M. M. A., Hydroquinone and psoralens in the therapy of hypermelanosis and vitiligo. Arch. Dermatol. 1966, 93, 589–600.
   PubMedGoogle Scholar
• Kligman A. M., Willis I., A new formula for depigmenting human skin. Arch. Dermatol. 1975, 111, 40–48.
   PubMed Web of Science ®Google Scholar
• Bleehen S. S., Skin bleaching preparations. J. Soc. Cosmet. Chem. 1977, 28, 407–412.
   Google Scholar
• Mishima Y., Hatta S., Ohyama Y., Inazu M., Induction of melanogenesis suppression: cellular pharmacology and mode of differential action. Pigment Cell Res. 1998, 1, 367–374.
   Google Scholar
• Breathnach A. C., Nazzaro-Porro M., Passi S., Azelaic acid therapy in disorders of pigmentation. Clin. Dermatol. 1989, 7, 106–119.
   PubMed Web of Science ®Google Scholar
• Verallo-Rowell V. M., Verallo V., Graupe K., Lopez-Villafuerte L., Garcia-Lopez M., Double-blind comparison of azelaic acid and hydroquinone in the treatment of melasma. Acta Dermatol. Venereol. 1989, 143, 58–61.
   Google Scholar
• Jimbow K., N-Acetyl-4-S-cysteaminylphenol as a new type of depigmenting agent for the melanoderma of melasma patients. Arch. Dermatol. 1991, 127, 1528–1534.
   PubMedGoogle Scholar
• Neering H., Treatment of melasma (chloasma) by local application of steroid cream. Dermatologica 1975, 151, 349–353.
   Google Scholar
• Kanwar A. J., Dhar S., Kaur S., Treatment of melasma with potent topical corticosteroids. Dermatology 1994, 188, 170.
   PubMed Web of Science ®Google Scholar
• Griffiths C. E. M., Finkel L. J., Ditre C. M., Hamilton T. A., Ellis C. N., Voorhees J. J., Topical tretinonin (retinoic acid) improves melasma: a vehicle-controlled clinical trial. Br. J. Dermatol. 1993, 129, 415–421.
   PubMed Web of Science ®Google Scholar
• Kimbrough-Green C. K., Griffiths C. E. M., Finkel L. J., Hamilton T. A., Burengo-Ransby S. M., Ellis C. N., Voorhees J. J., Topical retinoic acid (tretinoin) for melasma in black patients: a vehicle-controlled clinical trial. Arch. Dermatol. 1994, 130, 727–733.
   PubMed Web of Science ®Google Scholar
• Kenji O., Toshiyuki T., Tet suro I., Inhibitory effects of resveratrol derivatives from Dipterocarpaceae plants on tyrosinase activity. J. Biosci. Biotechnol. Biochem. 2003, 67, 1587–1589.
   Google Scholar
• Shin N H., Ryu S. Y., Choi E J., Oxyresveratrol as the potent inhibitor on DOPA oxidase activity of mushroom tyrosinase. J. Biochem. Biophys. Res. Commun. 1998, 243, 801–803.
   Google Scholar
• Hearing V. J., Jr., Methods in enzymology. Academic, 1987, 142, 155.
   Google Scholar
• Chen Q. X., Song K. K., Qiu L., Liu X. D., Huang H., Guo H. Y., Inhibitory effects on mushroom tyrosinase by p-alkoxybenzoic acids. Food Chem. 2005, 91, 269–274.
   Web of Science ®Google Scholar